Remarkable response to anti-PD1 immunotherapy in refractory metastatic high-grade myxofibrosarcoma patient: A case report

INTRODUCTION: Myxofibrosarcoma (MFS) is a locally aggressive tumor and has the potential to be fatal because of distant metastasis. Immunotherapy targeting either programmed cell death protein 1 (PD-1) or programmed death ligand 1 (PD-L1) has recently shown a curative effect on multiple cancers incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yi, Min, Li, Zhou, Yong, Tang, Fan, Lu, Minxun, Xie, Hongmei, Wang, Yitian, Duan, Hong, Zhang, Wenli, Tu, Chongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281969/
https://www.ncbi.nlm.nih.gov/pubmed/33761725
http://dx.doi.org/10.1097/MD.0000000000025262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281969/
https://www.ncbi.nlm.nih.gov/pubmed/33761725
http://dx.doi.org/10.1097/MD.0000000000025262

Ejemplares similares